当归水提物通过ERα诱导干性促进ER阳性乳腺癌生长
本研究探讨当归根水提物(AS)对雌激素受体(ER)阳性乳腺癌的促瘤效应及其机制。体外实验显示AS促进MCF-7细胞增殖、抑制MDA-MB-231细胞生长;体内异种移植模型中AS(2.5 mg/kg)显著诱导肿瘤生长,他莫昔芬可抑制该效应。AS通过诱导ERα表达增强ER阳性乳腺癌干细胞活性,提示乳腺癌患者使用当归需谨慎。
要点
- 当归水提物在ER阳性乳腺癌中可能通过ERα诱导干性促进肿瘤生长。
- 他莫昔芬可显著抑制当归诱导的肿瘤生长。
- 乳腺癌患者使用当归应权衡安全性,尤其ER阳性者。
核心结论
- 当归水提物通过ERα诱导干性对ER阳性乳腺癌发挥促瘤潜力,从安全性角度不建议乳腺癌患者使用。
研究设计与样本
- 体外细胞实验结合体内异种移植模型,研究当归水提物对ER阳性乳腺癌的作用及机制。
主要发现
- AS显著促进MCF-7细胞增殖并抑制MDA-MB-231细胞生长。
- AS在异种移植模型中显著诱导肿瘤生长(2.5 mg/kg),他莫昔芬处理显著抑制AS诱导的肿瘤生长。
- AS在体内外诱导ERα表达并促进ER阳性乳腺癌的癌症干细胞活性。
关键数值与推荐
- AS在异种移植模型中诱导肿瘤生长的剂量为2.5 mg/kg。
临床怎么用
- ER阳性乳腺癌患者应避免使用当归,或需在医生指导下评估风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: The root of Angelica sinensis is widely used in traditional Chinese Medicine for relieving gynecological discomforts among the women population. However, its hormone-like effects have raised great attention on whether it is appropriate to use in breast cancer (BC) patients. Hence, this study aimed to investigate the tumorigenic effect of aqueous root extract of Angelica sinensis (AS) on estrogen receptor (ER)-positive BC growth through ER-induced stemness in-vitro and in-vivo. MATERIALS AND METHODS: The chemical composition of the AS was characterized by HPLC. Cell viability was detected by MTS assay. The in-vivo effect of AS was investigated by xenograft model, immunohistochemistry, histology, Western blot, and self-renewal ability assay. Target verification was used by shRNA construction and transfection. Mammosphere formation assay was performed by flow cytometry. RESULTS: AS significantly promoted the proliferation of MCF-7 cells and inhibited the growth of MDA-MB-231 cells. AS significantly induced tumor growth (2.5 mg/kg) in xenograft models and however tamoxifen treatment significantly suppressed the AS-induced tumor growth. AS induced ERα expression in both in-vivo and in-vitro and promoted cancer stem cell activity in ER-positive BC. CONCLUSION: AS shows the tumorigenic potential on ER-positive BC growth through ERα induced stemness, suggesting that the usage of AS is not recommended for BC in terms of safety measures.
引用
- Zhu H, You J, Wen Y, et al. Tumorigenic risk of Angelica sinensis on ER-positive breast cancer growth through ER-induced stemness in vitro and in vivo. J Ethnopharmacol. 2021. PMID: 34271113. doi:10.1016/j.jep.2021.114415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。